B Medical Systems is a global manufacturer and distributor of medical-grade devices, specializing in cold chain solutions for the safe storage and transport of vaccines, blood components, and laboratory specimens.

B Medical Systems

Rhinomed Limited engages in the research, development, and commercialization of consumer and medical devices worldwide. It offers wearable nasal technology that improve breathing, sleeping, and maintaining health and diagnose disease. The company's products include Turbine for enhanced breathing in sports; Mute, which helps to breath more and snore less; Pronto, a vapor inhaler to improve airflow and better sleep; and Rhinoswab that is used to collect a nasal swab. It also engages in developing programs in various markets, including sleep and sleep architecture, the impact of sleep and respiratory, function on cognitive issues, obstructive sleep apnea, pain, nausea, respiratory disease, and diagnostics and sensors; and offers a drug delivery platform for the delivery of cannabinoid formulations. The company was formerly known as Consegna Group Limited and changed its name to Rhinomed Limited in November 2013. Rhinomed Limited was incorporated in 2004 and is headquartered in Cremorne, Australia.

Metric
Company Name	B Medical Systems	Rhinomed Limited
Symbol		RNO
MSH ID	COM:BMEDICALSYSTEMS	GLOBAL:RHINOMED
Market	PRIVATE	STOCKS
Sector	Healthcare & Health Services	Healthcare
Industry	Medical Equipment and Supplies	Medical - Devices
Country	LU	AU
Stage
Employee Count
Website	bmedicalsystems.com	rhinomed.global
LinkedIn
Founders

Metric
Market Cap		7.33M
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue		5.82M
Revenue (LTM)
Revenue (NTM)
Gross Profit		3.97M
EBITDA		-2.90M
Operating Income		-3.35M
Net Income		-3.37M
EPS		-0.01
Diluted EPS		-0.01
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin		0.33
Operating Profit Margin		-0.48
EBITDA Margin		-0.50
Net Profit Margin		-0.95
Return on Equity		5.28
Return on Assets
Return on Capital Employed

COM:BMEDICALSYSTEMS

B Medical Systems

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio		-0.73
P/B Ratio		-1.22
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio		1.00
EV Multiple		-2.89

Metric
Days Sales Outstanding		70.62
Days Payables Outstanding		336.54
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow		-4.59M
Free Cash Flow		-4.65M
Cash Flow to Debt
Operating Cash Flow/Sales		-0.94
Free Cash Flow Yield		-0.91

Metric
Cash & Equivalents		1.27M
Accounts Receivable		380.94K
Inventory		793.44K
Goodwill		999.99K
Debt to Capitalization
Debt to Assets		1.91
Current Ratio		0.27
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue		0.15
SG&A to Revenue		0.16